Skip to main content

Table 5 Estimated means (standard errors) for the TAU and the ACT group at all assessments

From: A randomised trial of Acceptance and Commitment Therapy for Anorexia Nervosa after daycare treatment, including five-year follow-up

  pre post 6 months 12 months 18 months 24 months 5 year
  TAU ACT TAU ACT TAU ACT TAU ACT TAU ACT TAU ACT TAU ACT
  M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE) M(SE)
BMI 17.6(0.4) 17.6(0.4) 18.5(0.5) 18.7(0.4)* 18.5(0.5) 19.3(0.5)** 19.0(0.5)* 19.2(0.5)** 19.5(0.5)** 19.7(0.5)** 20.2(0.6)*** 19.4(0.4)** 20.5(0.5)*** 20.1(0.4)***
EDE-Q 3.3(0.3) 3.1(0.2) 2.2(0.3) 2.1(0.3)*** 2.2(0.3)** 2.2(0.3)** 1.4(0.3)*** 2.0(0.3)** 2.3(0.3)* 2.4(0.3)* 2.5(0.4)* 2.4(0.3)* 1.9(0.3)** 2.3(0.3)*
Restraint 2.7(0.3) 2.5(0.3) 1.9(0.4) 2.0(0.4) 1.7(0.4) 2.0(0.4) 2.1(0.4) 2.4(0.4) 1.9(0.4) 2.0(0.4) 2.0(0.5) 2.4(0.4) 2.0(0.4) 2.3(0.4)
Eating 3.0(0.3) 3.0(0.2) 1.8(0.3)*** 1.5(0.3) 1.8(0.3) 1.7(0.3)** 0.8(0.3)*** 1.0(0.3)*** 1.9(0.3)** 1.9(0.3)** 1.6(0.3)** 1.7(0.3)** 1.5(0.3)*** 1.8(0.3)**
Shape 4.0(0.3) 3.9(0.3) 3.1(0.3)** 2.8(0.4)** 3.2(0.4) 3.1(0.4) 1.3(0.4)*** 2.4(0.4)** 3.1(0.4)* 3.3(0.4) 3.5(0.4) 3.2(0.4) 2.5(0.4)** 2.8(0.3)*
Weight 3.3(0.3) 3.2(0.3) 2.2(0.3)** 2.1(0.3)** 2.4(0.4)* 2.0(0.4)** 1.6(0.3)*** 2.1(0.4)* 2.4(0.4)* 2.1(0.4)** 2.6(0.4) 2.2(0.3)** 1.8(0.3)* 2.0(0.3)**
BSQ 114.6(5.9) 114.4(5.2) 100.7(6.1)** 91.0(6.2) 100.9(6.6) 94.3(7.0)** 100.0(6.3) 94.4(7.1)* 100.4(6.6) 97.9(6.9) 101.2(7.3) 94.6(6.4)*   
EDI               
 D 10.8(1.0) 10.6(0.9) 8.7(1.0)* 7.8(1.1)** 8.0(1.1)* 8.4(1.2) 7.8(1.1)* 7.8(1.2) 7.6(1.1) 7.4(1.2)* 8.8(1.3) 7.8(1.1)   
 B 1.2(0.4) 1.2(0.4) 0.6(0.4) 1.3(0.5) 1.9(0.5) 1.4(0.5) 1.5(0.4) 0.9(0.5) 1.9(0.5) 1.7(0.5) 1.5(0.6) 1.3(0.5)   
 Bd 15.2(1.1) 15.3(1.0) 13.6(1.2) 10.5(1.2) 14.3(1.3) 12.0(1.4)* 13.4(1.2) 11.2(1.4)** 13.7(1.3) 11.4(1.3)* 13.7(1.4) 10.8(1.2)*   
 Inef 10.5(1.1) 10.1(1.0) 5.3(1.2)*** 7.4(1.3)* 6.1(1.3)** 7.8(1.4) 7.2(1.2)* 10.2(1.4) 5.9(1.3)** 8.0(1.4) 7.2(1.5) 9.2(1.3)   
 Perf 5.9(0.7) 5.7(0.6) 5.2(0.7) 6.7(0.7) 5.7(0.8) 6.5(0.8) 6.0(0.7) 5.4(0.8) 5.2(0.8) 4.9(0.8) 4.7(0.8) 5.5(0.7)   
 Interp 3.1(0.5) 3.1(0.4) 2.0(1.5) 3.0(0.5) 1.9(0.5) 2.5(0.5) 2.7(0.5) 2.0(0.6) 2.4(0.5) 1.7(0.5) 2.0(0.6) 1.7(0.5)   
 Intero 8.6(1.1) 8.3(1.0) 4.7(1.2) 7.3(1.2) 6.1(1.3) 6.1(1.4) 6.7(1.2) 5.7(1.4) 5.9(1.3) 6.2(1.3) 4.2(1.4) 7.4(1.2)   
MADRS 20.1(2.0) 19.5(1.8) 12.4(2.1) 17.3(2.3) 15.1(2.4) 18.7(2.6) 12.5(2.2) 20.9(2.6) 13.4(2.3) 17.7(2.4) 13.7(2.8) 17.8(2.2)   
QOLI 0.5(0.3) 0.8(0.3) 1.7(0.3)*** 1.6(0.4)** 1.5(0.4)** 1.2(0.4) 1.5(0.4)* 1.1(0.4) 1.4(0.4) 1.3(0.4) 1.1(0.4) 0.8(0.4)   
RSE 1.8(0.4) 1.8(0.3) 3.0(0.4)** 3.4(0.4)*** 3.0(0.4)** 3.3(0.5)** 2.5(0.4) 2.8(0.5)* 3.1(0.4)* 2.4(0.5) 2.9(0.5) 2.3(0.4)   
  1. BMI body mass index, EDE-Q eating disorder examination questionnaire, BSQ body shape questionnaire, EDI eating disorder inventory (d drive for thinness, b bulimia, Bd body dissatisfaction, Inef ineffectiveness, \Perf perfectionism, interp interpersonal distrust, Intero interoceptive awareness), MADRS-S montgomery asberg depression rating scale self-report, QOLI quality of life inventory, RSE rosenberg self-esteem
  2. *p < .05, **p < .01, ***p < .001 significant time effect within each group from pre-measure